PGNYProgyny, Inc.

Nasdaq progyny.com


$ 21.19 $ 0.07 (0.31 %)    

Monday, 19-Aug-2024 14:20:22 EDT
QQQ $ 477.96 $ 2.30 (0.48 %)
DIA $ 408.31 $ 0.88 (0.22 %)
SPY $ 557.40 $ 2.51 (0.45 %)
TLT $ 97.97 $ 0.03 (0.04 %)
GLD $ 231.37 $ 1.17 (0.51 %)
$ 21.04
$ 21.13
$ 21.17 x 100
$ 21.20 x 200
$ 20.96 - $ 21.26
$ 19.60 - $ 42.08
1,212,765
na
2.06B
$ 1.31
$ 32.81
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-06-2021 06-30-2021 10-Q
14 05-07-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-10-2020 12-31-2019 10-K
20 12-06-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-overweight-on-progyny-lowers-price-target-to-31

JP Morgan analyst Anne Samuel maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $41 to $31.

 btig-downgrades-progyny-to-neutral

BTIG analyst David Larsen downgrades Progyny (NASDAQ:PGNY) from Buy to Neutral.

 jmp-securities-maintains-market-outperform-on-progyny-lowers-price-target-to-31

JMP Securities analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and lowers the price tar...

 cantor-fitzgerald-maintains-overweight-on-progyny-lowers-price-target-to-37

Cantor Fitzgerald analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $48...

 truist-securities-maintains-buy-on-progyny-lowers-price-target-to-33

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $37 to...

 canaccord-genuity-downgrades-progyny-to-hold-lowers-price-target-to-24

Canaccord Genuity analyst Richard Close downgrades Progyny (NASDAQ:PGNY) from Buy to Hold and lowers the price target from $...

 leerink-partners-downgrades-progyny-to-market-perform-lowers-price-target-to-25

Leerink Partners analyst Michael Cherny downgrades Progyny (NASDAQ:PGNY) from Outperform to Market Perform and lowers the pr...

 progyny-q2-2024-adj-eps-043-beats-017-estimate-sales-30409m-miss-30542m-estimate

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.17 by 152....

 jmp-securities-initiates-coverage-on-progyny-with-market-outperform-rating-announces-price-target-of-36

JMP Securities analyst Constantine Davides initiates coverage on Progyny (NASDAQ:PGNY) with a Market Outperform rating and a...

 progyny-reports-acquisition-of-berlin-based-fertility-benefits-platform-apryl-no-terms-disclosed

This acquisition enhances Progyny's guided, concierge support that enables employees around the world to navigate the compl...

 truist-securities-maintains-buy-on-progyny-lowers-price-target-to-37

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $46 to...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION